High Net Worth Advisory Group’s Gilead Sciences GILD Stock Holding History

High Net Worth Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$528K	Sell	3,786 -150	-4%	-$21K	0.12%	140
2025 Q4	$483K	Hold	3,936	–	–	0.11%	145
2025 Q3	$437K	Buy	3,936 +42	+1%	+$4.77K	0.11%	147
2025 Q2	$432K	Hold	3,894	–	–	0.11%	141
2025 Q1	$436K	Hold	3,894	–	–	0.12%	137
2024 Q4	$360K	Sell	3,894 -125	-3%	-$11.3K	0.1%	151
2024 Q3	$337K	Hold	4,019	–	–	0.09%	158
2024 Q2	$276K	Sell	4,019 -500	-11%	-$33.4K	0.08%	169
2024 Q1	$331K	Buy	4,519 +258	+6%	+$19.8K	0.1%	150
2023 Q4	$345K	Hold	4,261	–	–	0.13%	132
2023 Q3	$319K	Hold	4,261	–	–	0.13%	133
2023 Q2	$328K	Buy	4,261 +30	+0.7%	+$2.39K	0.13%	137
2023 Q1	$351K	Sell	4,231 -126	-3%	-$10.4K	0.14%	132
2022 Q4	$374K	Buy	4,357 +126	+3%	+$9.98K	0.15%	128
2022 Q3	$261K	Hold	4,231	–	–	0.11%	151
2022 Q2	$262K	Hold	4,231	–	–	0.11%	154
2022 Q1	$252K	Sell	4,231 -50	-1%	-$3.2K	0.09%	160
2021 Q4	$311K	Buy	+4,281	New	+$295K	0.11%	155

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

High Net Worth Advisory Group's GILD Position: Q1 2026 in Review

High Net Worth Advisory Group reduced its Gilead Sciences (GILD) stake by 3.8% in Q1 2026, selling an estimated $21K and leaving 3,786 shares worth $528K. The position accounts for 0.12% of the portfolio, ranked #140.

High Net Worth Advisory Group first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

High Net Worth Advisory Group held 3,786 shares of Gilead Sciences worth $528K as of Q1 2026.
High Net Worth Advisory Group sold 150 Gilead Sciences shares in Q1 2026, an estimated $21K.
Gilead Sciences made up 0.12% of High Net Worth Advisory Group's portfolio in Q1 2026, its #140 holding.
High Net Worth Advisory Group first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on High Net Worth Advisory Group's 13F filing for Q1 2026, filed 17 Apr 2026.